Test Price
2,800 AED✅ Home Collection Available
ASCL1 Gene Central Hypoventilation Syndrome (Congenital) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ASCL1 لمتلازمة نقص التهوية المركزية الخلقية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Certified Clinical Excellence
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
فحص جيني دقيق لتشخيص متلازمة نقص التهوية المركزية الخلقية في دولة الإمارات، معتمد من هيئة الصحة بدبي ويوفر استشارة وراثية شاملة، جمع عينات منزلي مبرد، ودعم سريري بعد النتيجة.
Test Overview & Comparative Advantage
The ASCL1 gene NGS test identifies pathogenic variants in the ASCL1 gene associated with Congenital Central Hypoventilation Syndrome (CCHS), a rare disorder of autonomic respiratory control. This advanced sequencing approach offers unparalleled coverage, detecting both known and novel mutations with high sensitivity, and is performed in a UAE-licensed facility to meet 2026 DHA guidelines.
| Feature | Our Test (NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene analysis | Sanger sequencing – limited to targeted regions |
| Variant Detection | SNVs, indels, large deletions/duplications (high uniform coverage) | Primarily SNVs and small indels; may miss large rearrangements |
| Turnaround Time | 3–4 Weeks | 5–6 Weeks |
| Sample Types | Whole Blood, Extracted DNA, or One Drop Blood on FTA Card | Whole Blood only (often larger volume) |
| Price (AED) | 2800 | 3200–3800 (estimate) |
| Clinical Sensitivity | >99% for ASCL1-related CCHS | ~95% for point mutations; N/A for large deletions |
Physician Insight & Safety Protocol
“As a physician, I understand the profound anxiety families experience when a newborn shows signs of respiratory irregularity. This test is a definitive step toward clarifying a diagnosis of congenital central hypoventilation syndrome, but it must always be interpreted alongside a full clinical evaluation. Please, do not discontinue prescribed medication without consulting your doctor.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Safety Red Flags
- Not suitable for individuals unable to provide a blood sample or buccal/FTA sample (e.g., severe skin conditions precluding contact).
- For minors, legal guardian consent is mandatory per UAE CDS Law 2026.
- If the patient experiences severe apnea episodes, cyanosis, or unresponsiveness, seek emergency medical attention immediately; this test is not an emergency diagnostic.
Patient FAQ & Clinical Guidance
What is the ASCL1 gene test for Congenital Central Hypoventilation Syndrome?
The ASCL1 gene test identifies disease-causing mutations in the ASCL1 gene linked to Congenital Central Hypoventilation Syndrome (CCHS), a rare neuro-respiratory disorder. Early genetic confirmation guides life-saving ventilation strategies and surveillance for associated conditions. Results are delivered with a clinician’s interpretive report.
يكشف تحليل جين ASCL1 عن الطفرات المسببة لمتلازمة نقص التهوية المركزية الخلقية، وهو اضطراب نادر في التحكم التلقائي بالتنفس. يساعد التشخيص الجيني المبكر في وضع خطة علاجية تشمل التهوية المناسبة ورصد المضاعفات.
How is the sample collected and what are the preparation steps?
A blood sample (or a single drop on FTA card) is collected by a certified phlebotomist during a scheduled home visit or at our facility. No fasting or medication changes are required, but a prior genetic counselling session to document family history is strongly advised to aid interpretation. The patient’s clinical history must be provided.
يتم جمع عينة دم (أو قطرة واحدة على بطاقة FTA) بواسطة أخصائي سحب دم معتمد خلال زيارة منزلية. لا حاجة للصيام أو تغيير الأدوية، ولكن ينصح بجلسة استشارة وراثية لتوثيق التاريخ العائلي للمساعدة في تحليل النتيجة.
How long do results take and how will I receive them?
The ASCL1 NGS test report is typically ready in 3‑4 weeks. A secure digital copy is sent via encrypted email, and a telephonic post‑ consultation with our clinical team is included to explain the findings in plain language. Follow‑up genetic counselling can be arranged upon request.
تصدر نتيجة تحليل جين ASCL1 خلال 3‑4 أسابيع. يتم إرسال نسخة رقمية مشفرة عبر البريد الإلكتروني، وتشمل الخدمة استشارة هاتفية بعد النتيجة لتوضيح النتائج بلغة واضحة، مع إمكانية ترتيب جلسة استشارة وراثية إضافية.
This service complies with Federal Decree-Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minors’ Consent), and UAE PDPL (Data Privacy). Facility licensed by DHA/MOHAP.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians